Shilpa Pharma Lifesciences Achieves Gold Medal for Sustainability Excellence

Shilpa Pharma Lifesciences Limited, a prominent subsidiary of Shilpa Medicare Limited, has recently been awarded the esteemed Gold Medal by EcoVadis, a globally recognized provider of sustainability ratings for businesses. This recognition is not just a badge of honor; it reflects the company's unwavering commitment to integrating environmental, social, and governance (ESG) principles into every aspect of its operations.

With an impressive score of 82 out of 100, Shilpa Pharma ranks among the top 2% of over 130,000 companies assessed by EcoVadis worldwide. This remarkable achievement underscores Shilpa Pharma's leadership in sustainable practices within the pharmaceutical industry, showcasing its dedication to creating a responsible and resilient enterprise.

Understanding EcoVadis Ratings

EcoVadis assesses companies based on four key areas: Environment, Labor and Human Rights, Ethics, and Sustainable Procurement. By excelling in these categories, Shilpa Pharma has positioned itself as one of the leading organizations recognized globally for its sustainable business operations. This reflects the increasing importance of sustainability in the healthcare sector and highlights Shilpa’s proactive approach to responsible business practices.

Voices from Leadership

Keshav Bhutada, the Chairman and Managing Director of Shilpa Pharma Lifesciences, shared insights regarding this remarkable milestone. He emphasized that sustainability and innovation are vital components of the company’s growth strategy as a Contract Development and Manufacturing Organization (CDMO). Bhutada stated, "The EcoVadis Gold Medal is a testament to our relentless efforts in responsible manufacturing, ethical governance, and inclusive growth, which create lasting value for patients and partners alike. We are excited to collaborate with more global innovative companies to further enhance our sustainability initiatives."

Strengthening Global Partnerships

Achieving the EcoVadis Gold Medal not only elevates Shilpa Pharma's credibility but also strengthens its position among global clients, investors, and partners. It enhances the company’s reputation as a trusted CDMO partner that places sustainability at the forefront of its operations. The acknowledgment from EcoVadis serves as a pivotal point for Shilpa, reinforcing its commitment to driving positive change in the pharmaceutical landscape.

About Shilpa Medicare Limited

Shilpa Medicare Limited is a leading Indian pharmaceutical company renowned for developing, manufacturing, and marketing active pharmaceutical ingredients (APIs), formulations, and biologics, specializing in oncology, infectious diseases, and specialty segments. With expertise in complex generics and novel drug delivery systems, Shilpa serves patients across more than 80 countries. For additional information, please visit www.vbshilpa.com.

Forward-Looking Statements

This document may contain forward-looking statements that describe the company's goals, plans, and expectations concerning future performance. Actual results may differ significantly due to various risks and uncertainties, such as regulatory approvals and market conditions. Shilpa Medicare assumes no obligation to update any forward-looking statements based on subsequent events or circumstances.